Stone X Group Inc. Genprex, Inc. Transaction History

Stone X Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 17, 2019	BUY	$1.2 - $1.85 $42,180 - $65,027	35,150 New	35,150 $44,000
Q2 2019 Jul 12, 2019	SELL	$1.2 - $1.85 $42,180 - $65,027	-35,150 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$1.0 - $2.15 $35,150 - $75,572	35,150 New	35,150 $38,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $39.9M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.